90 related articles for article (PubMed ID: 25137174)
1. [Intralesional rituximab in ocular adnexal lymphoma].
Crespo Robledo P; Vázquez Castillo MJ
Farm Hosp; 2014 Jul; 38(4):386-7. PubMed ID: 25137174
[No Abstract] [Full Text] [Related]
2. Intralesional rituximab in primary conjunctival follicular lymphoma relapsed.
Rodríguez Villa S; Ruiz Rodríguez MJ; Vargas Pabón M
Arch Soc Esp Oftalmol; 2017 Jul; 92(7):326-329. PubMed ID: 27986437
[TBL] [Abstract][Full Text] [Related]
3. Intralesional Rituximab for the Treatment of Recurrent Ocular Adnexal Lymphoma.
Demirci H; Kauh CY; Rajaii F; Elner VM
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S70-S71. PubMed ID: 26950471
[TBL] [Abstract][Full Text] [Related]
4. Local treatment for lymphoid malignancies of the eye.
Giuliari GP; Hinkle DM; Foster CS
Anticancer Agents Med Chem; 2009 Dec; 9(10):1123-8. PubMed ID: 19925396
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections.
Savino G; Battendieri R; Gari M; Caputo CG; Laurenti L; Blasi MA
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1251-5. PubMed ID: 23625184
[TBL] [Abstract][Full Text] [Related]
6. [Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin's lymphoma].
Fernández Cañabate E; Fernández-Cañabate S
Farm Hosp; 2018 Jan; 42(1):20-21. PubMed ID: 29306309
[TBL] [Abstract][Full Text] [Related]
7. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
8. Intralesional Rituximab Treatment for Primary Cutaneous B-cell Lymphoma: Nine Finnish Cases.
Väkevä L; Ranki A; Mälkönen T
Acta Derm Venereol; 2016 Mar; 96(3):396-7. PubMed ID: 26525093
[No Abstract] [Full Text] [Related]
9. Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.
Rigacci L; Nassi L; Puccioni M; Mappa S; Polito E; Dal Pozzo S; Alterini R; Carrai V; Puccini B; Bosi A
Ann Hematol; 2007 Aug; 86(8):565-8. PubMed ID: 17483948
[TBL] [Abstract][Full Text] [Related]
10. Intralesional Rituximab Injection for Low-Grade Conjunctival Lymphoma Management.
Demirci H; Ozgonul C; Diniz Grisolia AB; Elner VM
Ophthalmology; 2020 Sep; 127(9):1270-1273. PubMed ID: 32336490
[No Abstract] [Full Text] [Related]
11. Conjunctival and orbital lymphoma.
Shinder R
Ophthalmology; 2011 Aug; 118(8):1692; author reply 1692, 1692.e1. PubMed ID: 21813098
[No Abstract] [Full Text] [Related]
12. Follicular lymphoma of the ocular adnexal region: a nation-based study.
Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Specht L; Rossing HH; Siersma VD; Heegaard S
Acta Ophthalmol; 2015 Mar; 93(2):184-91. PubMed ID: 25125069
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous rituximab and chemotherapy achieves similar overall response rates to intravenous rituximab in first-line follicular lymphoma: efficacy and safety results of the phase III SABRINA study.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):6-7. PubMed ID: 25768992
[No Abstract] [Full Text] [Related]
14. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
15. Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Mino T; Mihara K; Yoshida T; Takihara Y; Ichinohe T
Blood Cancer J; 2014 Sep; 4(9):e245. PubMed ID: 25215661
[No Abstract] [Full Text] [Related]
16. Intraocular use of rituximab.
Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
[TBL] [Abstract][Full Text] [Related]
17. Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab.
Jensen M; Elter T; Engert A; Reiser M
Onkologie; 2006 Mar; 29(3):90-2. PubMed ID: 16514269
[TBL] [Abstract][Full Text] [Related]
18. Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab.
Muroi K; Sakata-Yanagimoto M; Sato T; Yokoyama Y; Maie K; Kurita N; Obara N; Hasegawa Y; Noguchi M; Chiba S
Ann Hematol; 2015 Dec; 94(12):2061-2. PubMed ID: 26240012
[No Abstract] [Full Text] [Related]
19. Intra-CSF rituximab for lymhomatous meningitis.
Chamberlain MC; Glantz MJ
J Clin Oncol; 2007 Oct; 25(28):4508-9; author reply 4509-11. PubMed ID: 17906219
[No Abstract] [Full Text] [Related]
20. Intraocular rituximab.
Singh AD; Peereboom DM
Eye (Lond); 2007 Dec; 21(12):1453-4. PubMed ID: 18159211
[No Abstract] [Full Text] [Related]
[Next] [New Search]